EUVIMEDEUVIMED entdecken
Crossref

Exosomal TGFBI promotes malignant progression of melanoma by regulating the FN1 signaling pathway

Yongliang Ge, Jingya Qiao, Lingling Ju, Lin Chen, Songnian Gao

Tissue and Cell · 2026-10 · 102 · 103609

DOI: 10.1016/j.tice.2026.103609 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tissue and Cell, 2026-10. Verfasst von Yongliang Ge und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Burn and Plastic Surgery, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, No. 60 Qingnian Middle …. Hauptthemen laut MEDLINE: Melanoma, Exosomes, Fibronectins, Signal Transduction. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE This study aimed to investigate the role and mechanism of exosomal Transforming Growth Factor Beta-Induced Protein (TGFBI) in the malignant progression of melanoma. METHODS Bioinformatics analyses of the GSE84683 and TCGA-SKCM datasets were performed. Exosomes were isolated from melanoma cell lines and characterized. A series of in vitro functional assays (CCK-8, wound healing, Transwell, tube formation) and in vivo xenograft models were used. Protein interaction was predicted by the STRING database and verified by co-immunoprecipitation (Co-IP). Rescue experiments were conducted to confirm the functional relationship. RESULTS TGFBI was significantly overexpressed in melanoma. TGFBI was enriched in melanoma-derived exosomes and could be delivered to recipient cells. Exosomal TGFBI promoted melanoma cell proliferation, migration, invasion, angiogenesis, and tumor growth in vivo. TGFBI was found to physically interact with Fibronectin 1 (FN1). FN1 overexpression reversed the suppressive effects of TGFBI knockdown on melanoma progression. CONCLUSION Exosomal TGFBI promotes the malignant progression of melanoma by interacting with and regulating FN1, revealing a potential therapeutic target for this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaExosomesFibronectinsSignal TransductionExtracellular Matrix ProteinsDisease ProgressionTransforming Growth Factor betaHumansAnimalsbetaIG-H3 ProteinCell Line, TumorCell ProliferationMiceCell MovementGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

ExosomeFN1MelanomaProgressionTGFBI

Substanzen

FibronectinsbetaIG-H3 ProteinExtracellular Matrix ProteinsTransforming Growth Factor betaFN1 protein, human

Autor:innen und Institutionen

  • Department of Burn and Plastic Surgery, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, No. 60 Qingnian Middle Road, Nantong, Jiangsu 226000, China.
  • Nantong Institute of Liver Diseases, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, No. 60 Qingnian Middle Road, Nantong, Jiangsu 226000, China.
  • Department of Rehabilitation, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, No. 60 Qingnian Middle Road, Nantong, Jiangsu 226000, China. Electronic address: Lwbz301@163.com.

Zitieren

APA

Ge, Y., Qiao, J., Ju, L., Chen, L., & Gao, S. (2026). Exosomal TGFBI promotes malignant progression of melanoma by regulating the FN1 signaling pathway. Tissue and Cell, 102, 103609. https://doi.org/10.1016/j.tice.2026.103609

Vancouver

Ge Y, Qiao J, Ju L, Chen L, Gao S. Exosomal TGFBI promotes malignant progression of melanoma by regulating the FN1 signaling pathway. Tissue and Cell. 2026;102:103609. doi:10.1016/j.tice.2026.103609

BibTeX
@article{Ge2026,
  author = {Ge, Yongliang and Qiao, Jingya and Ju, Lingling and Chen, Lin and Gao, Songnian},
  title = {Exosomal TGFBI promotes malignant progression of melanoma by regulating the FN1 signaling pathway},
  journal = {Tissue and Cell},
  year = {2026},
  volume = {102},
  pages = {103609},
  doi = {10.1016/j.tice.2026.103609}
}
Kostenlos starten →